U.S. Transportation Stock News

If you are looking at AZZ and wondering whether the current share price reflects its true value, the recent performance gives you plenty to think about. The stock last closed at US$141.58, with returns of 3.7% over 7 days, 15.4% over 30 days, 29.0% year to date, 61.8% over 1 year and 289.8% over 3 years, which naturally raises questions about what is already priced in. Recent coverage around AZZ has focused on its role in the capital goods space and ongoing interest from investors looking at...

Colgate-Palmolive (CL) stock has recently attracted attention as reports highlight expectations for first quarter 2026 revenue and earnings per share, supported by consumer demand and science based progress in Hill’s Pet Nutrition. See our latest analysis for Colgate-Palmolive. The recent earnings focus and upcoming shareholder votes sit alongside a share price of $85.67, with a 7 day share price return of 4.72% and year to date share price return of 10.27%. The 1 year total shareholder...

Investors may be wondering if Entegris at around US$144.72 is still priced fairly, or if the recent run has pushed it too far ahead of its underlying value. The stock has been volatile recently, with a 2.2% decline over the last 7 days, a 33.2% gain over the last month, a 61.6% return year to date, 83.6% over 1 year, 95.3% over 3 years, and 33.3% over 5 years. Recent coverage has focused on Entegris as a key semiconductor materials supplier, with attention on how its products fit into chip...

Sanmina (SANM) has just posted Q2 2026 numbers with revenue of about US$4.0 billion, basic EPS of US$1.72 and net income excluding extra items of US$93.6 million. These results draw attention to how the headline figures sit against its recent track record. Over the past six quarters, revenue has moved from about US$2.0 billion in Q2 2025 to roughly US$4.0 billion in Q2 2026, while quarterly EPS has ranged between US$0.90 and US$1.72. This gives investors plenty to weigh in terms of earnings...

BridgeBio Pharma recently reported that its heart drug Attruby is seeing accelerating uptake among new patients and prescribers, while also highlighting upcoming Phase III readouts across three rare disease programs and expanded educational efforts around ATTR-CM. The combination of a faster-than-expected commercial ramp for Attruby and a high-profile national awareness campaign suggests BridgeBio is rapidly shifting from a pipeline-focused biotech to a more fully built commercial rare...

SouthState Bank (SSB) has drawn fresh attention after recent share price moves, with the stock showing mixed returns over the past week, month and past 3 months while longer term performance remains positive. See our latest analysis for SouthState Bank. The recent 9.68% 1 month share price return, together with a modest 4.45% year to date share price gain and a 15.13% 1 year total shareholder return, suggests momentum has been improving after a softer 3 month patch as investors reassess...

Annaly Capital Management, Inc. reported first-quarter 2026 results showing net income of US$282.65 million and basic earnings per share from continuing operations of US$0.33, both more than double the figures a year earlier. The results highlight how Annaly’s move beyond Agency mortgage-backed securities into Residential Credit and Mortgage Servicing Rights has helped strengthen earnings in a volatile mortgage market. We will now examine how Annaly’s sharply higher quarterly earnings might...

HubSpot, trading as NYSE:HUBS, faces a shareholder proposal seeking the right for investors holding at least 10% of shares to call special meetings. The board has urged shareholders to vote against the proposal ahead of the upcoming annual shareholder meeting. The proposal focuses attention on investor rights and corporate governance practices at HubSpot. HubSpot enters this governance discussion with its shares at $225.97 and a value score of 4, which may catch the eye of investors...

With no single headline event driving Gilead Sciences (GILD) today, the focus shifts to how the stock’s recent performance, business mix and valuation metrics might inform your expectations for risk and return. See our latest analysis for Gilead Sciences. At a share price of $129.26, Gilead’s recent 1 month share price return of 5.19% and 90 day share price return of 7.37% contrast with a 1 year total shareholder return of 24.55% and 5 year total shareholder return of 134.15%. This suggests...

Alliance Resource Partners (ARLP) opened Q1 2026 with revenue of US$516 million and basic EPS of US$0.07, alongside trailing twelve month EPS of US$1.89 on revenue of about US$2.2 billion. This sets a clear snapshot of recent scale and earnings power. Over the past year, the partnership has seen quarterly revenue move between US$516 million and US$571 million, while basic EPS has ranged from US$0.07 to US$0.73, with trailing net profit margin sitting near 11.2%. For investors, that...

LifeStance Health Group (LFST) is drawing fresh interest after S&P Dow Jones Indices said the behavioral health provider will join the S&P SmallCap 600, prompting index tracking funds to start buying shares. See our latest analysis for LifeStance Health Group. The latest S&P SmallCap 600 announcement comes on top of a 22.92% 30 day share price return and a 16.74% 1 year total shareholder return. This suggests momentum has picked up recently even though longer term returns remain mixed. If...

If you are wondering whether DTE Energy is priced attractively right now, starting with what the current share price implies about value can help you frame your next move. The stock last closed at US$148.58, with returns of 3.6% over 7 days, 2.8% over 30 days, 14.0% year to date, 12.3% over 1 year, 47.6% over 3 years and 46.3% over 5 years, which gives you a clear snapshot of how the market has treated the shares across different timeframes. Recent headlines around DTE Energy have focused on...

Dell Technologies recently presented at Hannover Messe 2026 in Germany, while analysts highlighted growing demand for its AI-focused servers and infrastructure solutions. Together with a multi-billion-dollar AI infrastructure agreement and rising expectations for very large earnings growth, these developments underscore Dell’s expanding role in enterprise AI workloads. Next, we’ll examine how this accelerating AI infrastructure demand, including Dell’s large Boost Run agreement, may...

If you are wondering whether AGCO at around US$115 a share still offers value, you are not alone. Many investors are asking the same question right now. The stock has been uneven in the short term, with a 3.4% decline over the last week, a 1.5% gain over the last month, and returns of 8.9% year to date and 36.6% over the last year. Recent coverage has focused on AGCO's position in capital goods and agriculture equipment, as investors reassess companies tied to food production and farm...

Earlier this month, Sunoco LP announced a higher quarterly distribution of US$0.9899 per common unit (US$3.9596 annualized) for the March 31, 2026 quarter, a 6.25% increase over the prior quarter, payable on May 20, 2026 to holders of record on May 8, 2026. This distribution increase, coming alongside analyst expectations for materially higher near-term earnings, highlights how management is backing up a stronger operating outlook with higher cash returns to unitholders. We’ll now examine...

Calix (CALX) has drawn fresh attention after reporting first quarter revenue of US$279.98 million and net income of US$11.21 million. The company also increased its share repurchase authorization by US$100 million to US$525 million. See our latest analysis for Calix. Despite the increased buyback authorization and fresh quarterly numbers, Calix’s share price has come under pressure, with a 30 day share price return showing a 16.41% decline and a 90 day share price return showing a 20.64%...

In late April 2026, Procter & Gamble reported third-quarter fiscal 2026 results showing sales of US$21,235 million and net income of US$3,932 million, alongside reaffirmed full-year guidance for modest all-in sales and diluted EPS growth. These results, combined with P&G’s 70th consecutive annual dividend increase and ongoing product launches in categories like air care and haircare, underline how the company is pairing steady cash returns with continued brand innovation. With P&G’s earnings...

What Axalta’s Zencore Launch Means for Stock Watchers Axalta Coating Systems (AXTA) has introduced Zencore, a cabinet coating system that combines primer and enamel into one platform, aiming to simplify production for high volume manufacturers across North America. The launch focuses on reducing coating steps, SKU complexity, and rework while targeting consistent finish quality. This gives investors a fresh operational data point to consider alongside recent share price performance. See our...

In April 2026, Harmonic’s partners DIRECTV, NAGRAVISION and CentralCast announced deployments of Harmonic’s VOS Media Software and XOS Advanced Media Processor to streamline large-scale video workflows, cut operating costs and support higher-quality broadcast and streaming delivery. Together, these wins underscore how Harmonic’s cloud-native, API-driven and watermarking-enabled platforms are becoming embedded in critical broadcast and OTT infrastructure across pay-TV, public media and live...

Wondering whether TransUnion at around US$70 a share looks cheap, expensive, or somewhere in between? This article walks through the numbers so you can judge the price tag with more confidence. The stock is down about 9.5% over the last week and 15.9% year to date, while the 3 year return sits at 7.1%. These mixed figures can leave you questioning whether recent moves point to improving prospects or rising concerns. Recent headlines have focused on TransUnion as one of the major credit data...

Kimberly-Clark (KMB) opened 2026 with Q1 revenue of US$4.2 billion and basic EPS of US$1.70, setting a clear earnings-season marker for investors focused on both top and bottom line. Over the last six reported quarters, revenue has moved in a tight band between US$4.1 billion and US$4.2 billion, while quarterly basic EPS has ranged from roughly US$1.01 to US$1.70, giving a consistent view of how sales are translating into per share earnings. With trailing net profit margins lower than a year...

Recent share performance and business mix With no single headline event driving Azenta (AZTA), attention has turned to its recent share performance and business profile, especially after a month return of about 22% following weaker results over the past 3 months. The company focuses on biological and chemical compound sample exploration and management for life sciences customers, and splits its operations between Sample Management Solutions and Multiomics services. See our latest analysis for...

For readers wondering whether EchoStar's recent share price places it in bargain or stretched territory, this article breaks down what the numbers indicate about value. At a last close of US$123.70, EchoStar has recorded returns of 1.1% over 7 days, 10.2% over 30 days, 10.3% year to date and a 1 year gain of 450.3%, with a 3 year return of 661.2% and a 5 year return of 427.1%. Recent headlines around EchoStar have focused on its sharp share price move and what that implies for expectations...

If you are wondering whether Kenvue's current share price lines up with its underlying worth, this article walks through what the numbers are actually saying about value. Kenvue shares last closed at US$17.54, with returns of 1.4% over 7 days, 0.1% over 30 days, 1.3% year to date and a 21.8% decline over the past year. Recent coverage has focused on Kenvue's position as a standalone consumer health company following its separation from Johnson & Johnson and how investors are assessing the...